Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920569 · ClinicalTrials.gov registry record
Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation
A clinical trial, sponsored by Transonic Systems.
- Terminated
- Registry status
- 8
- Enrollment target
NCT00920569: Clinical Trial study, sponsored by Transonic Systems.
NCT00920569 is a clinical trial that was terminated before completion, run by Transonic Systems. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00920569 was terminated before completion, sponsored by Transonic Systems.
- TERMINATED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This study is to test the usefulness of ultrasound dilution measurements in patients on extracorporeal membrane oxygenation. Measurements may include; efficiency of support (recirculation), amount of clotting in the oxygenator (oxygenator blood volume), and how well the heart is working (cardiac output). At the present time there are no devices available to perform these functions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-05 |
| Est. Completion | 2008-08 |
Why NCT00920569 stopped before completion
NCT00920569 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00920569 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00920569 about?
NCT00920569 is a clinical study titled "Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation". This study is to test the usefulness of ultrasound dilution measurements in patients on extracorporeal membrane oxygenation. Measurements may include; efficiency of support (recirculation), amount of clotting in the oxygenator (oxygenator blood volume), and how well the heart is working (cardiac out...
What is the current status of trial NCT00920569?
This trial is currently terminated. The enrollment target is 8 participants. The study started on 2006-05. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00920569?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia